Tag: FDA drug label analysis

Get a Second Opinion today announced the nationwide debut of Pre‑Prescription Intelligence, a real‑time medication decision system that gives every patient clear visibility into efficacy, safety, interactions, and cost before a prescription is written. The platform delivers personalized guidance without requiring any personally identifiable information (PII), making it the first national‑scale medication intelligence system built…

Continue reading…